Hyderabad, July 29, 2019: Dr. Reddy's Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated…
Revenue at Rs. 2,182 Crore up 5% YoY; EBITDA at Rs 444 Crores down 1% YoY PAT at Rs 185…
The margins have improved from 10% in FY2011 to 23% in FY2019 Growth is attributed to revenues derived from niche…
Revenue for Q4 FY19 of INR 2,579 Million, a growth of 16% (y-o-y) and for FY19 of INR 9,787 Million,…
JUBILANT REPORTS RECORD PERFORMANCE IN FY'19 Revenue up 21% YoY to Rs. 9,111 Crore; EBITDA up 14% YoY to Rs 1,775…
To expand its services to five more cities apart from Delhi-NCR Targets expansion in South East Asia, Africa and Middle…
Hyderabad, February 02, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY |NYSE: RDY) today announced its consolidated financial…
Sales increased by 4.4 percent to EUR 1.79 billion in the third quarter EBITDA pre exceptionals 1.5 percent higher at…
Operating margin drops from 15.0% in Q2 FY2018 to 13.3% In Q2 FY2019 Structurally, in the long term, underlying fundamentals…
Net Sales up (YoY) to Rs. 26.72 crore Registers a net profit of Rs.4.49 crore EPS for the second quarter…